Wesley H. Kaupinen

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP

Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA.

Synthes Spine Co. offers implants and instruments for the treatment of fractures, tumors, deformities, and degenerative diseases affecting the spine. Its products include plates, screws, rods, cables, and hooks designed to stabilize the spine. Synthes Spine was founded in 1998 and is headquartered in West Chester, PA.

Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania.